{
    "clinical_study": {
        "@rank": "122727", 
        "acronym": "SENTIJAMBE", 
        "arm_group": {
            "arm_group_label": "isotopic intraoperative detection", 
            "arm_group_type": "Experimental", 
            "description": "Lower-limb drainage isotopic intraoperative detection"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate the feasibility of an isotopic technique to\n      identify, and to map the lower-limb drainage nodes during pelvic lymphadenectomy for\n      gynaecological cancers. The diagnostic value of our mapping method will be assessed, and we\n      will determine the incidence of lymhedema."
        }, 
        "brief_title": "Lower-Limb Drainage Mapping in Pelvic Lymphadenectomy for Gynaecological Cancer", 
        "completion_date": {
            "#text": "December 2020", 
            "@type": "Anticipated"
        }, 
        "condition": "Gynaecological Malignant Tumours With Indication of Pelvic Lymphadenectomy", 
        "condition_browse": {
            "mesh_term": "Neoplasms"
        }, 
        "detailed_description": {
            "textblock": "Pelvic lymphadenectomy is associated with a significant risk of lower-limb lymphedema. In\n      this study, we evaluate the feasibility of identifying the lower-limb drainage nodes (LLDNs)\n      during pelvic lymphadenectomy for gynaecological cancers using an isotopic detection\n      technique with a preoperative radiopharmaceutical injection into both feet Secondary\n      objectives are to map lower-limb drainage, to assess the diagnostic value of our mapping\n      technique, and to determine the incidence of lymphedema. LLDN mapping may allow the\n      preservation of LLDNs, thereby decreasing the risk of lower-limb lymphedema and improving\n      quality of life."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Female patients 18 years of age or older with indication of pelvic lymphadenectomy\n             for gynaecological malignancy:\n\n               -  High risk endometrial cancer (stage IB type I grade 3, stage I  type II, stage>\n                  IB) or with metastatic sentinel lymph node,\n\n               -  Early cervical cancer, or with metastatic sentinel lymph node,\n\n               -  Ovarian cancer.\n\n          -  Must provide her signed and informed consent\n\n          -  Beneficiary of a health insurance\n\n          -  Having received a medical examination\n\n        Exclusion Criteria:\n\n          -  Contraindication to pelvic lymphadenectomy\n\n          -  Presence of lymphedema of the lower limbs\n\n          -  Contraindication to radiomarkers (allergy or hypersensitivity to any component of the\n             biomarker)\n\n          -  Patient with dementia or altered mental status\n\n          -  Pregnant or breast feeding patients\n\n          -  Participation in any other clinical trial that could interfere with the study results"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "55", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 17, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01946672", 
            "org_study_id": "P110903"
        }, 
        "intervention": {
            "arm_group_label": "isotopic intraoperative detection", 
            "description": "A radiopharmaceutical is injected into both feet on the day before surgery. Pelvic lower-limb drainage nodes (LLDNs) are identified using preoperative SPECT-CT and intraoperative isotopic probe detection, and then electively removed before complete pelvic lymphadenectomy. LLDNs and pelvic lymphadenectomy specimens undergo separate histological analysis.", 
            "intervention_name": "Lower-limb drainage isotopic intraoperative detection", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "gynaecological malignancy", 
            "pelvic lymphadenectomy", 
            "lymphedema", 
            "sentinel node", 
            "reverse mapping"
        ], 
        "lastchanged_date": "September 17, 2013", 
        "location": {
            "contact": {
                "email": "anne-sophie.bats@egp.aphp.fr", 
                "last_name": "Anne-Sophie BATS, MD, PhD", 
                "phone": "+33156093586"
            }, 
            "contact_backup": {
                "email": "gilles.chatellier@egp.aphp.fr", 
                "last_name": "Gilles CHATELLIER, MD, PhD", 
                "phone": "+33156093020"
            }, 
            "facility": {
                "address": {
                    "city": "Paris", 
                    "country": "France", 
                    "state": "Ile-de-France", 
                    "zip": "75"
                }, 
                "name": "HEGP"
            }, 
            "investigator": {
                "last_name": "Anne-Sophie BATS, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "1", 
        "official_title": "Individualisation du Drainage Lymphatique Des Membres inf\u00e9rieurs Lors du Curage Pelvien Pour Cancer gyn\u00e9cologique", 
        "overall_contact": {
            "email": "anne-sophie.bats@egp.aphp.fr", 
            "last_name": "Anne-Sophie BATS, MD, PhD", 
            "phone": "+33156093586"
        }, 
        "overall_contact_backup": {
            "email": "anne-spphie.bats@egp.aphp.fr", 
            "last_name": "Anne-Sophie BATS, MD, PhD", 
            "phone": "+33156093586"
        }, 
        "overall_official": {
            "affiliation": "assistance publique des hopitaux de paris", 
            "last_name": "Anne-Sophie BATS, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Committee for the Protection of Personnes", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "December 2020", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Lower-limb drainage intraoperative isotopic detection rate in patients with pelvic lymphadenectomy for gynaecological cancers.", 
            "safety_issue": "No", 
            "time_frame": "day of surgery"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01946672"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Anatomy of lower-limb drainage", 
                "safety_issue": "No", 
                "time_frame": "day of surgery"
            }, 
            {
                "measure": "Percentage of patients with metastatic lower limb sampling", 
                "safety_issue": "No", 
                "time_frame": "2 weeks after surgery"
            }, 
            {
                "measure": "Follow-up of patients to identify complications, and namely lower-limb lymphedema.", 
                "safety_issue": "No", 
                "time_frame": "5 years"
            }
        ], 
        "source": "Assistance Publique - H\u00f4pitaux de Paris", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Assistance Publique - H\u00f4pitaux de Paris", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "January 2013"
    }
}